Cancer Charity-funded

Worldwide Cancer Research

Research funded by Worldwide Cancer Research

Funded awards
461
Published funding
£77.5M
Average published award
£168K
Active funded awards
0
Search funded awards from Worldwide Cancer Research →

Worldwide Cancer Research funds most in Cancer — 293 grants (64%). Its largest recipient is University of Dundee, with 15 grants.

Funded Awards by Year

View data table
YearFunded awards
200646
200754
200846
200944
201036
201137
201225
201340
201432
201536
201632
201819
201914

Grants

The Regulation of DNA Replication InitiationThe Gurdon InstituteWCR£1.2M2010Completed
Defining the role of the Fanconi Anaemia tumour suppressor Pathway in DNA crosslink repair and replication fork stability.University of OxfordWCR£898K2007Completed
Uncovering the cellular and molecular basis of tumor heterogeneity in skin squamous cell carcinomaUniversite Libre de Bruxelles (ULB)WCR£274K2015Completed
Development of a novel pro-angiogenic approach for cancer therapyQueen Mary University of LondonWCR£261K2012Completed
Identification of mutations driving lung squamous cell carcinomaWalter and Eliza Hall Institute of Medical ResearchWCR£260K2014Completed
MYC antagonist MNT: a new target for blood cancersWalter and Eliza Hall Institute of Medical ResearchWCR£250K2019Completed
DNA damage associated R-loops as targets for chemotherapeutic interventionErasmus MCWCR£250K2018Completed
Dissecting the cellular origin and the molecular mechanisms of Down Syndrome-associated TMD and AMKLFondazione Centro San RaffaeleWCR£250K2019Completed
Harnessing miRNAs to restore CTL immunity to cancerErasmus MCWCR£249K2016Completed
Early Detection Markers for Gastroesophageal Cancer; a Proteomic Perspective of Epithelial-Stromal Crosstalk.University of CambridgeWCR£248K2019Completed
Targeting regulation of senescence in SWI/SNF-mutant liver cancerImperial College LondonWCR£244K2018Completed
Dendritic cell-based immunotherapy: an induced pluripotent stem cell approach.King's College LondonWCR£242K2018Completed
TIL Recruitment and Activation in Triple Negative Breast CancerMonash UniversityWCR£237K2018Completed
Targeting PKN2 to suppress stromal activation in pancreatic ductal adenocarcinoma.Queen Mary University of LondonWCR£236K2018Completed
A Calculus for Tracking Development of Non-Hodgkin’s LymphomaWalter and Eliza Hall Institute of Medical ResearchWCR£229K2018Completed
Chlomipramine derivatives to target the ubiquitin ligase NEDD4 in lung cancerIfom the Firc Institute of Molecular Oncology FoundationWCR£229K2019Completed
Sex-specific predisposition in adrenal cancerINSERM U1091 Institut de Biologie de Valrose (IBV)WCR£228K2018Completed
Social jet lag: a cancer risk factor?Erasmus MCWCR£223K2016Completed
Dynamic interplay between ZEB2 and LSD1 in pre-leukemic stem cells and malignant T cell transformationGhent UniversityWCR£222K2016Completed
Mechanisms of resistance to anti-TGF-beta therapies in metastatic colorectal cancerInstitute for Research in Biomedicine (IRB Barcelona)WCR£219K2019Completed

Page 1 of 3